Early detection through these simple tests can go a long way in preventing chronic kidney disease and the need for dialysis ...

Conversely, patients with low risk for graft failure can be discharged from the care of their transplant nephrologist and ...

Dr. Christopher Kelly: A biomarker is a biological substance that can be objectively measured and tracked to provide ...

Impaired kidney function was also identified as a key risk factor for heart disease, contributing to about 12% of global ...

Researchers uncovered how fatty molecules called ceramides trigger acute kidney injury by damaging the mitochondria that ...

A pig kidney with one genetic change functioned in a brain-dead human for 61 days, more than doubling previous records.

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.

In this video, Anjay Rastogi, MD, PhD, professor and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, discusses the screening process for chronic kidney disease.

Doctors at New York University say two new studies show that they are a significant step closer to making cross-species kidney transplants a real option in the near future.

Background: Among patients with focal segmental glomerulosclerosis (FSGS), proteinuria and kidney function decline may be ...

Findings suggest that urinary ceramide levels could serve as an early biomarker for acute kidney injury, helping doctors identify patients at risk.